Kodiak Sciences (KOD) Capital Expenditures (2017 - 2026)
Kodiak Sciences (KOD) posted Capital Expenditures of $942000.0 for Q1 2026, up 2090.7% on a QoQ basis from $43000.0 in Q4 2025, and up 248.89% year-over-year from $270000.0 in Q1 2025.
Kodiak Sciences (KOD) Capital Expenditures (2017 - 2026) Analysis & Trends
Kodiak Sciences' Capital Expenditures history runs 10 years deep, the most recent figure standing at $942000.0 for Q1 2026.
- Quarterly Capital Expenditures rose 248.89% year-over-year to $942000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 89.09% YoY) and the FY2025 annual result came in at $506000.0, up 34.93% from the prior year.
- Capital Expenditures was $942000.0 for Q1 2026 at Kodiak Sciences, up from $43000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $27.5 million in Q4 2023 and bottomed at $22000.0 in Q1 2024.
- A 5-year average of $4.7 million and a median of $270000.0 in 2025 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures soared 1311.48% — and 2024, when it plunged 99.82%.
- Kodiak Sciences' Capital Expenditures stood at $3.1 million in 2022, then surged by 797.29% to $27.5 million in 2023, then slumped by 99.55% to $124000.0 in 2024, then slumped by 65.32% to $43000.0 in 2025, then surged by 2090.7% to $942000.0 in 2026.
- Business Quant data shows KOD's Capital Expenditures at $942000.0 in Q1 2026, $43000.0 in Q4 2025, and $60000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | 942,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 942,000.00 |
| Mar 31, 2026 | 942,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 270,000.00 |
| Mar 31, 2025 | 270,000.00 |
| Dec 31, 2024 | 124,000.00 |
| Dec 31, 2024 | 124,000.00 |
| Sep 30, 2024 | 180,000.00 |
| Sep 30, 2024 | 180,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 27.48 Mn |
| Dec 31, 2023 | 27.48 Mn |